Supplemental Experimental Procedures
Cell culture
All cell lines and fibroblasts were kept in DMEM, except for MCC13 cells which were kept in RPMI. Media were supplemented with 10% FCS (Sigma-Aldrich) and with 1% each of pen-strep, sodium pyruvate, L-glutamine and non-essential amino acids (Biological Industries).
Primary and secondary antibodies used in this study
The following primary antibodies were used for flow cytometry The following antibodies were used for blocking assays: anti-NKG2D (clone 149810, R&D Systems) and anti-CD99 (12E7, used as an isotype control, was a gift from A. Bernard, INSERM, France).
The following primary antibodies were used for western blotting: anti-HA tag (clone 3F10, Roche), anti-HIS tag (AD1.1.10, R&D systems), anti-MICA (clone 1.7AD (Zou et al., 2002) , or clone EPR6568, Abcam), anti-PP2AC
(rabbit polyclonal, Abcam) anti-GAPDH (clone 6C5, Santa Cruz) and anti-vinculin (clone EPR8185, Abcam).
The following secondary antibodies were used for western blotting: anti-mouse-HRP, anti-rat-HRP and antirabbit-HRP, all purchased from Jackson laboratories.
Primers and templates used for cloning and PCR mutagenesis
MICA*004, MICA*008 and MICB were amplified from cDNA and cloned into the lentiviral vector SIN18-pRLL-hEFIap-E-GFP-WRPE by replacing the GFP with the desired sequence. US9 was amplified from cDNA derived from HCMV-infected cells (TB40/E strain) and cloned into the lentiviral vector pHAGE-DsRED(−)-eGFP(+) which also contains GFP.
The following primers were used for the initial cloning of US9, MICA*004, MICA*008 and MICB (all primers are listed 5' to 3'): 
TGTTGCGTTGTTGTAAGAAGAAAACATCAGCTGC
The two resulting PCR fragments were then unified using the MICA FW and MICA*004 REV primers.
For preparation of the chimera MICA*008-ULBP3TM, MICA*008 was used as template for amplifying the extracellular portion, with the following primers:
MICA*008-ULBP3TM REV (used with MICA FW) -TATGGCTTTGGGTTGAGCTAACCAATGACTCTGAAGCACCAG ULBP3 was used as template for the transmembrane domain, with the following primers:
The two resulting PCR fragments were then unified using the MICA FW and ULBP3TM REV primers.
For introducing a C-terminus truncation into US9, the following primer was used: US9-truncated REV (used with the US9 FW primer) -
GGGATCCTTAAGCGTAATCTGGAACATCGTATGGGTAGCCTCTTCCTCGGACCCAGGGAC
For swapping MICB's transmembrane portion with that of MICA*008, MICB's extracellular portion was amplified from the MICB lentiviral construct using the MICB FW primer with the MICB-mut REV primer -
ACAGCAGAAACATGGAATGTCTGGTCTGTCCGTTGACTCTGAAGC
The MICA*008 construct was used as template for amplifying the transmembrane portion using the MICA*008 REV primer and MICA*008-TM FW primer -
GCTTCAGAGTCAACGGACAGACCAGACATTCCATGTTTCTGCTGT
The two resulting PCR fragments were then unified using the MICB FW and MICA*008 REV primers.
ΔUS9 HCMV mutant generation
The US9 deletion mutant (ΔUS9) was generated according to a previously published procedure (Wagner et al., 2002) Briefly, a PCR fragment was generated using primers DeltaUS9-Kana1 CCCAACAGCAGCCCAGGCCGACGAGGAGGCGCAGCCACCGCCTCATGGCGGCTTCGCCAGCCAGTG AATTCGAGCTCGGTAC and DeltaUS9-Kana2 CTCCCGCACACAGACGACGCGCCGGGCGGCTTCCTGCGGCCGGCCGCGGTGCCGGCGGCTGACCAT GATTACGCCAAGCTCC. The PCR fragment containing a kanamycin resistance gene was inserted into the parental BAC by homologous recombination in E. coli. Recombinant mutant virus was reconstituted from BAC DNA by Superfect (Qiagen) transfection into HCMV-permissive cells.
Viral infection
HFF were used to propagate all HCMV strains and virus stocks were titrated using a plaque assay and stored at -80°C. Infection with the various virus strains was carried out at a multiplicity of infection (MOI) of 2-4, in confluent fibroblasts. HCMV infection was enhanced by centrifugation at 800 g for 30 min. Mock-infected fibroblasts were incubated with medium only, and were plated at a lower density so they would be sub-confluent at the time point in which the infected cells were harvested for further analyses. Infection was verified by intracellular FACS staining with anti-CMV antibody (clone 8B1.2, Merck Millipore) at 24 hpi, and at least 85% of the cells were infected.
qRT-PCR
Total RNA was isolated by using the Quick RNA Miniprep kit (Zymo) according to the manufacturer's instructions. Total RNA (0.25-2 μg) was reverse transcribed with mMLV Reverse Transcriptase (Invitrogen) and with 0.5 μg of poly(T) 3′ rapid amplification of complementary DNA ends (RACE) adaptor using the FirstChoice RLM-RACE kit (Ambion), according to the manufacturer's instructions. Quantitative PCR was used to measure mRNA expression was as follows: cDNA was mixed with 150 μM of both the forward and reverse primers in a final volume of 5 μl and mixed with 5 μl of SYBR Green qPCR SuperMix-UDG with ROX (Invitrogen). hUBC and hHPRT were used as endogenous reference genes for PCR quantification. PCR was performed on QuantStudio12K Flex Real Time PCR System (Applied Biosystems).
The following primers were used (listed from 5' to 3'):
hHPRT FW -TGACACTGGCAAAACAATGCA hHPRT REV -GGTCCTTTTCACCAGCAAGCT hUBC FW -ATTTGGGTCGCGGTTCTTG hUBC REV -TGCCTTGACATTCTCGATGGT
